vimarsana.com

Page 278 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advanced Chemotherapy Technologies, Inc Announces $2 5M Series A Investment by Spectrum Financial

Press release content from Business Wire. The AP news staff was not involved in its creation. Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial February 11, 2021 GMT Advanced Chemotherapy Technologies ACT-IOP-003 iontophoresis chemotherapy delivery system (Photo: Business Wire) RALEIGH, N.C. (BUSINESS WIRE) Feb 10, 2021 Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a Series A investment of $2.5 million with Spectrum Financial. This investment is in addition to the previously announced Series A investment of $5.5 million lead by Khosla Venture. The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.

A plant s nutrient-sensing abilities can modulate its response to environmental stress

 E-Mail Palo Alto, CA Understanding how plants respond to stressful environmental conditions is crucial to developing effective strategies for protecting important agricultural crops from a changing climate. New research led by Carnegie s Zhiyong Wang, Shouling, Xu, and Yang Bi reveals an important process by which plants switch between amplified and dampened stress responses. Their work is published by Nature Communications. To survive in a changing environment, plants must choose between different response strategies, which are based on both external environmental factors and internal nutritional and energy demands. For example, a plant might either delay or accelerate its lifecycle, depending on the availability of the stored sugars that make up its energy supply.

Health coalition rejects call for Northern Ontario bubble

However, members do call for tight and clear travel restrictions Author of the article: PJ Wilson Publishing date: Feb 10, 2021  •  February 10, 2021  •  4 minute read  •  This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, green, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. PHOTO BY SUPPLIED /The Canadian Press Article content Northern Ontario “can’t afford people coming up from southern Ontario” as a more virulent form of the novel coronavirus is spreading, Northern members of the Ontario Health Coalition said Wednesday.

Viewpoint: The Horizon Papers and the need for fair play in EU research

Call them “The Horizon Papers”: For the past few weeks, Science|Business has been publishing European Commission documents leaked to us concerning Horizon Europe, the next EU R&D programme. I want to explain why, and why it should matter to anybody who cares about progress in science and technology.

Anti-inflammatory drug shown to reduce risk of death for hospitalized Covid-19 patients

Tocilizumab, an intravenous anti-inflammatory drug used for rheumatoid arthritis, has been shown to reduce the risk of death for patients hospitalized with severe Covid-19, as well as reducing the risk of ventilation and the amount of time until discharged from hospital.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.